Immunosuppressive monoclonal antibodies: current and next generation.
about
A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory proteinIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesPharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis.Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
P2860
Immunosuppressive monoclonal antibodies: current and next generation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunosuppressive monoclonal antibodies: current and next generation.
@en
Immunosuppressive monoclonal antibodies: current and next generation.
@nl
type
label
Immunosuppressive monoclonal antibodies: current and next generation.
@en
Immunosuppressive monoclonal antibodies: current and next generation.
@nl
prefLabel
Immunosuppressive monoclonal antibodies: current and next generation.
@en
Immunosuppressive monoclonal antibodies: current and next generation.
@nl
P2093
P1476
Immunosuppressive monoclonal antibodies: current and next generation.
@en
P2093
P304
P356
10.1111/J.1469-0691.2011.03677.X
P577
2011-10-13T00:00:00Z